The expansion process through new acquisition which we had undertaken will continue as we had achieved 14 per cent growth rate.

We will not enter into direct sales but rather go for indirect sales.

The health care product will be on the line of similar product that the company has introduced in US and in other countries.

We believe the growth will also be rapid in Taiwan.

A slump in growth will continue until rising U.S. demand triggers an export-led recovery in Asia, most likely by mid-2003.

This is a report that suggests that economic growth is slowing very sharply. It's a report that indicates growth will probably only be moderate in the fourth quarter this year and in the first half of next year.